AIT THERAPEUTICS INC - NASDAQ: $AITB Waking Up
After breaking to higher ground last month and subsequently consolidating/digesting the move, it appears that AIT THERAPEUTICS INC - NASDAQ:AITB is starting to wake-up once again as yesterday's action indicates when observing the Daily chart above.
With the stock trading above all of its important moving averages 20/50/200 DMA's, AITB finds itself in a technically healthy posture.
While there is no doubt that AITB is 'Thinly' traded, it certainly appears that buyers came into the stock yesterday and we may just witness some follow-through in the days/weeks ahead.
Thus, both investors/traders may want to continue to monitor the action in AITB for additional clues/evidence with regards to potential further advance moving forward. Should AITB be capable of clearing the $6.25 hurdle at any point moving forward, we may just witness a move into the $9 - $10 zone.
With the stock trading above all of its important moving averages 20/50/200 DMA's, AITB finds itself in a technically healthy posture.
While there is no doubt that AITB is 'Thinly' traded, it certainly appears that buyers came into the stock yesterday and we may just witness some follow-through in the days/weeks ahead.
Thus, both investors/traders may want to continue to monitor the action in AITB for additional clues/evidence with regards to potential further advance moving forward. Should AITB be capable of clearing the $6.25 hurdle at any point moving forward, we may just witness a move into the $9 - $10 zone.
To receive our alerts via email and SMS, join Insider Financial for Free at signup.insiderfinancial.com
We are not financial advisors. Always conduct your own research and read our full disclaimer at insiderfinancial.com/disclaimer/
We are not financial advisors. Always conduct your own research and read our full disclaimer at insiderfinancial.com/disclaimer/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.